Biological Products, Except Diagnostic Substances (Biotech) - Latest Activist Disclosures

This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

Date Form Target Company Investor Shares Ownership
(Percent)		 Ownership Change
(Percent)
2023-10-02 13D NMRA / Neumora Therapeutics, Inc. ARCH Venture Fund XII, L.P. 29,797,376 19.60
2023-09-29 13D SCLX / Scilex Holding Company SCLX Stock Acquisition JV LLC 89,616,299 39.30
2023-09-28 13D/A ABCZF / Abcam Limited Milner Jonathan 14,156,202 6.15
2023-09-27 13D/A HLVX / HilleVax, Inc. Frazier Life Sciences Public Fund, L.P. 9,806,472 20.20 0.26
2023-09-27 13D NMRA / Neumora Therapeutics, Inc. Amgen Inc 35,368,653 23.20
2023-09-26 13D/A SCLX / Scilex Holding Company Sorrento Therapeutics, Inc. 1,917,210 1.30 -97.99
2023-09-21 13D/A PROK / ProKidney Corp. Palihapitiya Chamath 14,573,000 23.70
2023-09-21 13D/A IBRX / ImmunityBio, Inc. Cambridge Equities, LP 650,212,966 82.80 69.00
2023-09-18 13D/A IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) General Atlantic Llc 2,606,684 5.30 -8.73
2023-09-15 13D/A HUMA / Humacyte, Inc. Niklason Laura E 10,050,822 9.50 -13.45
2023-09-14 13D/A ABCZF / Abcam Limited Milner Jonathan 14,124,702 6.14
2023-08-22 13D/A HUMA / Humacyte, Inc. Niklason Laura E 11,612,809 11.10 -16.52
2023-08-21 13D/A TSHA / Taysha Gene Therapies, Inc. Manning Paul B 23,476,333 12.60 235.86
2023-08-18 13D/A TSHA / Taysha Gene Therapies, Inc. Astellas Pharma Inc. 7,266,342 3.89
2023-08-16 13D/A ABCZF / Abcam Limited Milner Jonathan 14,111,202 6.14 -2.22
2023-08-15 13D/A SCLX / Scilex Holding Company Sorrento Therapeutics, Inc. 95,533,509 43.30 0.00
2023-08-11 13D/A VOR / Vor Biopharma Inc. Ra Capital Management, L.p. 22,780,343 33.70 0.09
2023-07-28 13D APGE / Apogee Therapeutics, Inc. Venrock Healthcare Capital Partners III, L.P. 3,887,478 9.99
2023-07-25 13D/A ABOS / Acumen Pharmaceuticals, Inc. Ra Capital Management, L.p. 14,981,618 25.90 53.27
2023-07-21 13D APGE / Apogee Therapeutics, Inc. Fairmount Funds Management LLC 3,906,202 9.99
2023-07-21 13D TTNP / Titan Pharmaceuticals, Inc. Choong Choon Hau 3,747,968 24.95
2023-07-11 13D/A ARMP / Armata Pharmaceuticals, Inc. Innoviva, Inc. 64,178,259 85.30 0.00
2023-06-30 13D/A VALN / Valneva SE - Depositary Receipt (Common Stock) Bpifrance Participations SA 12,801,207 9.20 10.20
2023-06-29 13D/A PASG / Passage Bio, Inc. Orbimed Advisors Llc 8,034,000 14.70 17.43
2023-06-27 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-23 13D/A TTNP / Titan Pharmaceuticals, Inc. Activist Investing LLC 0 0.00 -100.00
2023-06-23 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-23 13D/A ACLX / Arcellx, Inc. New Enterprise Associates 15, L.P. 3,745,262 7.80 -21.09
2023-06-22 13D/A ZURA / Zura Bio Limited Athanor Capital, Lp 7,995,633 18.55 17.55
2023-06-21 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-20 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28
2023-06-16 13D/A PMCB / PharmaCyte Biotech, Inc. Iroquois Capital Management, LLC 189,350 4.99 -84.76
2023-06-15 13D/A IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) General Atlantic Llc 2,855,897 5.90 -11.46
2023-06-15 13D TBIO / Telesis Bio, Inc. Novalis LifeSciences Investments II, L.P. 7,419,984 19.99
2023-06-15 13D/A HUMA / Humacyte, Inc. Niklason Laura E 13,911,388 13.20 -25.95
2023-06-15 13D/A PASG / Passage Bio, Inc. Frazier Life Sciences IX, L.P. 2,543,698 4.70 -32.29
2023-06-12 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-07 13D/A TBIO / Telesis Bio, Inc. Northpond Ventures, LP 18,306,873 47.90 85.97
2023-06-06 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-05 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.00
2023-06-05 13D/A KYMR / Kymera Therapeutics, Inc. Vertex Pharmaceuticals Inc / Ma 0 0.00 -100.00
2023-06-02 13D/A EXEL / Exelixis, Inc. Caligan Partners LP 910,730 0.28 7.14
2023-06-02 13D/A EXEL / Exelixis, Inc. Farallon Capital Partners, L.P. 25,860,000 7.90 10.20
2023-06-02 13D/A ACLX / Arcellx, Inc. Sr One Capital Management, Llc 3,946,630 8.22 -12.05
2023-06-02 13D/A TBIO / Telesis Bio, Inc. Northpond Ventures, LLC 9,844,130 33.10
2023-06-02 13D/A TCRX / TScan Therapeutics, Inc. Baker Bros. Advisors Lp 2,793,938 6.50 0.33
2023-05-30 13D/A ABCZF / Abcam Limited Milner Jonathan 14,431,202 6.28 0.02
2023-05-26 13D/A HUMA / Humacyte, Inc. Niklason Laura E 18,786,211 17.90 -15.89
2023-05-26 13D/A INKT / MiNK Therapeutics, Inc. Agenus Inc 21,522,157 62.50 0.83
2023-05-25 13D BCDA / BioCardia, Inc. Daly Joseph Patrick 758,540 3.75 0.00